Intuitive wins CE mark for da Vinci 5
July 2, 2025
Intuitive Surgical (Nasdaq: ISRG)+
announced today that it received CE mark for its da Vinci 5 surgical robotic system.
Intuitive Surgical (Nasdaq: ISRG)+
announced today that it received CE mark for its da Vinci 5 surgical robotic system.
Fasikl announced that it received FDA 510(k) clearance for its first-of-its-kind NeuroAI wristband for essential tremor.
A new hydrogel-based platform to preserve live patient-derived tumor tissues in the lab could pave the way for faster, more accurate testing of cancer treatments for patients with peritoneal metastases, a hard-to-treat and often deadly form of abdominal and pelvic cancers.
Researchers have shown, for the first time, that speckle contrast optical spectroscopy (SCOS) can be used for cuffless blood pressure monitoring. The new technology could improve early detection and management of hypertension.
PARIS and SAN FRANCISCO, July 2, 2025 /PRNewswire/ — Moon Surgical, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two major advancements to its Maestro System: connectivity of the platform to power the Maestro Insights product and a Predetermined Change Control Plan (PCCP) to evolve its AI-powered ScoPilot product.
Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant.
OSLO, Norway, July 1, 2025 /PRNewswire/ — SonoClear AS today announced that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has designated the SonoClear® System as a Breakthrough Device for use in intracranial ultrasound procedures.
Regulatory Approval Paves the Way for U.S. Market Launch of Innovative Therapy Targeting Chronic Pain and Neurological Disorders
Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.
New cutting-edge software developed in Melbourne can help uncover how the most common heart tumor in children forms and changes. And the technology has the potential to further our understanding of other childhood diseases, according to a new study.